Urinary kallikrein in Dahl-Iwai salt-sensitive and -resistant rats

American Journal of Hypertension

Volumn 10, Issue 5 II SUPPL., 1997, Pages

  Yoshida, Hideaki ^a   Nakagawa, Motoya ^a   Aoyama, Tohru ^a   Takizawa, Hideki ^a   Higashiura, Katsuhiro ^a   Ura, Nobuyuki ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dahl rat; hypertension; kallikrein; salt; Sprague Dawley rat

Indexed keywords

KALLIKREIN; KININ;

ANIMAL MODEL; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HYPERTENSION; KALLIKREIN KININ SYSTEM; KALLIKREIN URINE LEVEL; NONHUMAN; PRIORITY JOURNAL; RAT; SALT LOADING;

EID: 0031010404     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(97)90010-8     Document Type: Conference Paper

References (24)

1. Elliot AH, Nuzum FR. The urinary excretion of a depressor substance (kallikrein of Frey and Kraut) in arterial hypertension. Endocrinology. 18:1934;462-474.
2. Margolius HS, Geller R, Pisano JJ, et al. Altered urinary kallikrein excretion in human hypertension. Lancet. ii:1971;1063-1065.
3. Margolius HS. Tissue kallikrein and kinins: regulation and roles in hypertensive and diabetic diseases. Annu Rev Pharmacol. 29:1989;343-364.
4. Nakahashi Y, Shimamoto K, et al. Comprehensive studies on the renal kallikrein-kinin system in essential hypertension. Greenbaum LM, Margolius HS. Kinins IV. Part B. Advance in Experimental Medicine & Biology Series. 1988:1986;351-357 Plenum Press, New York.
5. Berry TD, Hasstedt SJ, Hunt SC, et al. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension. 13:1989;3-8.
6. Margolius HS, Horwitz D, Pisano JJ, Keiser HR. Urinary kallikrein excretion in hypertensive man: relationships to sodium intake and sodium-retaining steroids. Circ Res. 35:1974;820-825.
7. Zinner SH, Margolius HS, Rosner B, Kass EH. Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow up. Circulation. 58:1978;908-915.
8. Margolius HS, Geller RG, de Jong W, et al. Altered urinary kallikrein excretion in rats with hypertension. Circ Res. 30:1972;358-362.
9. Ader JL, Pollock DM, Butlerfield MJ, Arendshorst WJ. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am J Physiol. 248:1985;F396-F403.
10. Rapp JP. Dahl salt-susceptible and salt-resistant rats. Hypertension. 4:1982;753-763.
11. Rapp JP, Dene H. Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension. 7:1985;340-349.
12. Carretero OA, Amin VM, Ocholik T, et al. Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt: A new radioimmunoassay for its direct determination. Circ Res. 42:1978;727-732.
13. Rapp JP, McPartland RP, Batten CL. Isoelectric focusing pattern of urinary kallikrein in Dahl salt-hypertension susceptible and resistant rats. Hypertension. 6:1984;519-525.
14. Arbeit LA, Serra SR. Decreased total and active urinary kallikrein in normotensive Dahl salt susceptible rats. Kidney Int. 28:1985;447-455.
15. St Lezin EM, Pravenec M, Wong A, et al. Genetic contamination of Dahl SS/Jr rats: impact on studies of salt-sensitive (Brookhaven) rats. Hypertension. 23:((part 1)):1994;786-790.
16. Lewis JL, Russel RJ, Warnock DG. Analysis of the genetic contamination of salt-sensitive Dahl/Rapp rats. Hypertension. 24:1994;255-259.
17. Yamazaki K, Katoh H, Yamamoto N, et al. Characterization of new inbred strains of Dahl-Iwai salt-sensitive and salt-resistant rats. Lab Anim Sci. 44:1994;462-467.
18. Shimamoto K, Margolius HS, Chao J, Crosswell AR. A direct radioimmunoassay of rat urinary kallikrein and comparison with other measures of urinary kallikrein activity. J Lab Clin Med. 94:1979;172-179.
19. Shimamoto K, Tanaka S, Nakao T, et al. Measurement of urinary kallikrein activity by kinin radioimmunoassay. Jpn Circ J. 43:1979;147-152.
20. Chao J, Chai KX, Chen LM, et al. Tissue kallikrein-binding protein is a serpin. J Bio Chem. 265:1990;16394-16401.
21. Zhou GX, Chao L, Chao J. Kallistatin: a novel human tissue kallikrein inhibitor. J Bio Chem. 267:1992;25873-25880.
22. Nakagawa M, Stewart JM, Vavrek RJ, Nasjletti A. Effect of an antagonist on renal function in rats. Am J Physiol. 1990;F643-F648.
23. Chao J, Shimamoto K, Margolius HS. Measurement of rat urinary plasminogen activator (Esterase A) by direct radioimmunoassay in urine and tissue. Hoppe-Seyler's Z Physiol Chem. 365:1984;1137-1144.
24. Sustarsic DL, McPartland RP, Papp JP. Total and kallikrein arginine esterase activities in the urine of salt-hypertensive susceptible and resistant rats. Hypertension. 2:1980;813-820.